Evidence map›Paper›PMID 37641036›Full record

ArticleBMC nephrology2023

A novel likely pathogenic CLCN5 variant in Dent's disease.

S Hayward, J Norton, L Bownass, C Platt, Genomics England Research Consortium, H Campbell, E Watson, N Forrester, S Smithson, A Menon

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC nephrology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

S HaywardBristol Medical School, Translational Health Sciences, University of Bristol, Bristol, UK.
J NortonSouth West Genetic Laboratory Hub, North Bristol NHS Trust, Bristol, UK.
L BownassDepartment of Clinical Genetics, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
C PlattDepartment of Paediatric Nephrology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
Genomics England Research Consortium
H CampbellRichard Bright Renal Service, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.
E WatsonSouth West Genetic Laboratory Hub, North Bristol NHS Trust, Bristol, UK.
N ForresterSouth West Genetic Laboratory Hub, North Bristol NHS Trust, Bristol, UK.
S SmithsonDepartment of Clinical Genetics, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
A MenonRichard Bright Renal Service, Southmead Hospital, North Bristol NHS Trust, Bristol, UK. Anjali.Menon@nbt.nhs.uk.
North Bristol NHS Trust · GBSouthmead Hospital · GBUniversity Hospitals Bristol and Weston NHS Foundation TrustUniversity Hospitals Bristol NHS Foundation Trust · GBUniversity of Bristol · GBGenomics England · GB

Funding

Cancer Research UKDepartment of HealthMedical Research Council MR/W000105/1Wellcome Trust
6 · The paper itself

Abstract

backgroundThe majority of cases of Dent's disease are caused by pathogenic variants in the CLCN5 gene, which encodes a voltage-gated chloride ion channel (ClC-5), resulting in proximal tubular dysfunction. We present three members of the same family and one unrelated paediatric patient with the same insertion-deletion CLCN5 variant. The identification of these patients and positive familial segregation led to the re-classification of this variant from one of unknown significance to one of likely pathogenicity. CASE PRESENTATION: A 41 year old male presented with end stage kidney failure, proteinuria and haematuria. Whole genome sequencing identified an insertion-deletion variant in CLCN5, resulting in a missense change (c.1744_1745delinsAA p.(Ala582Lys)). His brother and nephew, who both exhibited renal impairment, haematuria, proteinuria, glycosuria and nephrocalcinosis, were found to have the same variant. In addition, genetic testing of an unrelated paediatric patient who presented with proteinuria and hypercalciuria, demonstrated the same variant.

conclusionsThe identification of this novel variant in four individuals with features of Dent's disease, has led to the re-classification of the variant to one of likely pathogenicity. As a result, our patients and any future patients with the same variant can be offered a likely diagnosis, without the need for kidney biopsy, and their family members can be offered genetic screening.

Indexed as

Dent DiseaseAdultChildChloridesFamilyHematuriaHumansMaleProteinuriaChloridesCLCN5Dent’s diseaseGeneticsNephrocalcinosisProteinuria

Identifiers

PMID37641036
PMCPMC10463507
OpenAlexW4386220115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.